indolepropionic acid has been researched along with Non-alcoholic Fatty Liver Disease in 1 studies
indolepropionic acid: structure in third source
3-(1H-indol-3-yl)propanoic acid : An indol-3-yl carboxylic acid that is propionic acid substituted by a 1H-indol-3-yl group at position 3.
Non-alcoholic Fatty Liver Disease: Fatty liver finding without excessive ALCOHOL CONSUMPTION.
Excerpt | Relevance | Reference |
---|---|---|
" One of the tryptophan derivatives, indolepropionic acid (IPA), is increasingly being studied as a marker for the onset and development of metabolic disorders, including type 2 diabetes (T2D) and non-alcoholic fatty liver disease (NAFLD)." | 9.22 | Indolepropionic Acid, a Gut Bacteria-Produced Tryptophan Metabolite and the Risk of Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease. ( de Mello, VD; Lindström, J; Männistö, V; Pihlajamäki, J; Sehgal, R; Tuomilehto, J; Uusitupa, M, 2022) |
" One of the tryptophan derivatives, indolepropionic acid (IPA), is increasingly being studied as a marker for the onset and development of metabolic disorders, including type 2 diabetes (T2D) and non-alcoholic fatty liver disease (NAFLD)." | 5.22 | Indolepropionic Acid, a Gut Bacteria-Produced Tryptophan Metabolite and the Risk of Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease. ( de Mello, VD; Lindström, J; Männistö, V; Pihlajamäki, J; Sehgal, R; Tuomilehto, J; Uusitupa, M, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Sehgal, R | 1 |
de Mello, VD | 1 |
Männistö, V | 1 |
Lindström, J | 1 |
Tuomilehto, J | 1 |
Pihlajamäki, J | 1 |
Uusitupa, M | 1 |
1 review available for indolepropionic acid and Non-alcoholic Fatty Liver Disease
Article | Year |
---|---|
Indolepropionic Acid, a Gut Bacteria-Produced Tryptophan Metabolite and the Risk of Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease.
Topics: Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Bacteria; Diabetes Mellitus, Type 2; Humans; Liver; N | 2022 |